An Open-label, One-sequence Cross-over, Single Centre Trial Investigating the Influence of Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug After Multiple Dose Administration of Semaglutide in Subjects With Type 2 Diabetes.
Phase of Trial: Phase I
Latest Information Update: 10 Feb 2017
At a glance
- Drugs Ethinylestradiol/levonorgestrel; Semaglutide
- Indications Pregnancy; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 20 Jan 2012 Actual patient number (43) added as reported by ClinicalTrials.gov.
- 20 Jan 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
- 20 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.